Jeffrey Stein - Jun 7, 2024 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role
President & CEO, Director
Signature
/s/ Shane Ward, Attorney-in-Fact
Stock symbol
CDTX
Transactions as of
Jun 7, 2024
Transactions value $
$105,680
Form type
4
Date filed
6/11/2024, 06:26 PM
Previous filing
May 31, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CDTX Common Stock Purchase $106K +8K +48.25% $13.21 24.6K Jun 7, 2024 By trust F1, F2
holding CDTX Common Stock 57.9K Jun 7, 2024 Direct F2, F3
holding CDTX Common Stock 2.1K Jun 7, 2024 By son F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.05 to $13.29, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
F2 The number of securities reported herein have been adjusted to reflect the 1-for-20 reverse stock split effected by the Issuer on April 24, 2024.
F3 Includes 200 shares acquired pursuant to the Issuer's Employee Stock Purchase Plan on May 20, 2024.